Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
75 hedge funds and large institutions have $40.2M invested in Genesis Healthcare, Inc. in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 22 reducing their positions, and 10 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 22
3% less funds holding
Funds holding: 77 → 75 (-2)
14% less capital invested
Capital invested by funds: $46.6M → $40.2M (-$6.4M)
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Chevy Chase Trust
Bethesda,
Maryland
|
+$2.97M |
| 2 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
+$445K |
| 3 |
Millennium Management
New York
|
+$352K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$323K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$296K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
-$3.34M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$479K |
| 3 |
JP Morgan Chase
New York
|
-$332K |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$218K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$119K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
CIBC Private Wealth Group
Atlanta,
Georgia
| – | -$34K | -25,000 | Closed |
|
77
Stifel Financial
St. Louis,
Missouri
| – | -$34K | -25,000 | Closed |
|
|
PPA
78
Parametric Portfolio Associates
Seattle,
Washington
| – | -$20K | -14,648 | Closed |
|
|
CSS
79
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$14K | -10,102 | Closed |
|
|
FDCDDQ
80
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$13.5K | -10,000 | Closed |
|
81
UBS Group
Zurich,
Switzerland
| – | -$4.56K | -3,076 | Closed |
|
|
PHK
82
Point72 Hong Kong
Hong Kong
| – | -$3K | -2,578 | Closed |
|
83
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | -1,248 | Closed |
|
|
MAM
84
Meeder Asset Management
Dublin,
Ohio
| – | -$1K | -888 | Closed |
|
GEN Hedge Fund Activity: Q4 2018 in Review
75 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q4 2018, worth a combined $40.2M — down 14% from $46.6M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of GEN and 8 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 21 added.
The largest buyer was Chevy Chase Trust, opening a new position worth an estimated $2.97M. The largest seller was HighTower Advisors, cutting an estimated $3.34M.
- 75 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q4 2018, down from 77 in Q3 2018.
- Funds reported $40.2M of Genesis Healthcare, Inc. stock for Q4 2018, down 14% quarter-over-quarter.
- 8 funds opened new Genesis Healthcare, Inc. positions in Q4 2018 and 10 closed out, a net change of -2 holders.
- The largest Genesis Healthcare, Inc. buyer in Q4 2018 was Chevy Chase Trust, an estimated $2.97M added.
- The largest Genesis Healthcare, Inc. seller in Q4 2018 was HighTower Advisors, an estimated $3.34M sold.
Based on aggregated 13F filings for Q4 2018.